Effects of recombinant human growth hormone on plasma and dialysate amino acid profiles in CAPD patients

Kidney International

Volumn 50, Issue 1, 1996, Pages 229-234

  Ikizler, T Alp ^b   Wingard, Rebecca L ^b   Flakoll, Paul J ^b   Schulman, Gerald ^b   Parker, Robert A ^b   Hakim, Raymond M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANABOLIC AGENT; HUMAN GROWTH HORMONE;

AMINO ACID BLOOD LEVEL; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIALYSATE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; MALE; MUSCLE METABOLISM; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN DEGRADATION; RANDOMIZED CONTROLLED TRIAL;

EID: 0029811744     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.306     Document Type: Article

References (30)

1. YOUNG, GA, KOPPLE JD, LINDHOLM B, VONESH EF, DEVECCHI A, SCALAMOGNA A, CASTELNOVA C, OREOPOULOS DG, ANDERSON GH, BERGSTROM J, DICHIRO J, GENTILE D, NISSENSON A, SAKHRANI L, BROWNJOHN AM, NOLPH KD, PROWANT BF, ALGRIM CE, MARTIS L, SERKES KD: Nutritional assessment of continous ambulatory peritoneal dialysis patients: An international study. Am J Kidney Dis 17:462-471, 1991
2. SPIEGEL DM, ANDERSON M, CAMPBELL U, HALL K, KELLY G, MCCLURE E, BREYER JA: Serum albumin a marker for morbidity in peritoneal dialysis patients. Am J Kidney Dis 21:26-30, 1993
3. TEEHAN BP, SCHLEIFER CR, BROWN J: Adequacy of continuous ambulatory peritoneal dialysis: Morbidity and mortality in chronic peritoneal dialysis. Am J Kidney Dis 24:990-1001, 1994
4. HAKIM RM: Clinical implications of hemodialysis membrane biocompatibility. Kidney Int 44:484-494, 1993
5. BRUNO M, BAGNIS C, MARANGELLA M, ROVERA L, CANIALUPPI A, LINARI F: CAPD with an amino acid dialysis solution: A long-term, cross-over study. Kidney Int 35:1189-1194, 1989
6. IKIZLER TA, WINGARD RL, HAKIM RM: Future approaches to the treatment of malnutrition. Perit Dial Int 15(Suppl):S63-S66, 1995
7. IKIZLER TA, WINGARD RL, HAKIM RM: Interventions to treat malnutrition in dialysis patients: The role of the dose of dialysis, intradialytic parenteral nutrition, and growth hormone. Am J Kidney Dis 26:256-265, 1995
8. KOPPLE J: The rationale for the use of growth hormone or insulin-like growth factor-1 in adult patients with renal failure. Miner Electrol Metab 18:264-275, 1992
9. MEHLS O, RITZ E, HUNZIKER EB, EGGLI P, HEINRICH U, ZAPF J: Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 33:45-52, 1988
10. CHWALS W, BISTRIAN B: Role of exogenous growth hormone and insulin-like growth factor 1 in malnutrition and acute metabolic stress: A hypothesis. Crit Care Med 19:1317-1322, 1991
11. IKIZLER TA, WINGARD RL, BREYER JA, SCHULMAN G, PARKER RA, HAKIM RM: Short-term effects of recombinant human growth hormone in CAPD patients. Kidney Int 46:1178-1183, 1994
12. BIDLINGMEYER B, COHEN S, TARVIN T: Rapid analysis of amino acids using pre-column derivatization. J Chromatogr Biomed Appl 336:93-104, 1984
13. WILMORE DW, MOYLAN JA JR, BRISTOW B, MASON AD JR, PRUITT BA JR: Anabolic effects of human growth hormone and high caloric feedings following thermal injury. Surg Gynecol Obstet 138:875-884, 1974
14. ZIEGLER TR, YOUNG LS, MANSON JM, WILMORE DW: Metabolic effects of recombinant human growth hormone in patients receiving parenteral nutrition. Ann Surg 208:6-16, 1988
15. MANSON JM, SMITH RJ, WILMORE DW: Growth hormone stimulates protein synthesis during hypocaloric parenteral nutrition. Ann Surg 208:136-142, 1988
16. THOMPSON WA, LOWRY SF: Role of growth factors in nutritional support, in Clinical Nutrition: Parenteral Nutrition, edited by ROMBEAU JL, CALDWELL MD, Philadelphia, W.B. Saunders, 1993, p 223
17. FRYBURG DA, BARRETT EJ: Growth hormone acutely stimulates skeletal muscle hut not whole-body protein synthesis in humans. Metabolism 42:1223-1227, 1993
18. JIANG ZM, HE GZ, ZHANG SY, WANG XR, YANG NF, ZHU Y, WILMORE DW: Low-dose growth hormone and hypocaloric nutrition attenuate the protein-eatabolic response after major surgery. Ann Surg 210:513-525, 1989
19. FRYBURG DA, GELFAND RA, BARRETT EJ: Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol 260:E499-E504, 1991
20. WOLF RF, PEARLSTONE DB, NEWMAN E, HESLIN MJ, GONENNE A, BURT ME, BRENNAN MF: Growth hormone and insulin reverse net whole body and skeletal muscle protein catabolism in cancer patients. Ann Surg 216:280-288, 1992
21. MJAALAND M, UNNEBERG K, LARSSON J, NILSSON L, REVHAUG A: Growth hormone after abdominal surgery attenuated forearm glutamine, alanine, 3-methylhistidine, and total amino acid efflux in patients receiving total parenteral nutrition. Ann Surg 217:413-422, 1993
22. KAPLAN SL: The newer uses of growth hormone in adults. Adv Int Med 38:287-301, 1993
23. INOUE Y, COPELAND EM, SOUBA WW: Growth hormone enhances amino acid uptake by the human small intestine. Ann Surg 219:715-724, 1994
24. TONSHOFF B, HAFFNER D, MEHLS O, DIETZ M, RUDER H, BLUM W, HEINRICH U, STOVER B: Efficacy and safety of growth hormone treatment in short children with renal allografts: Three year experience. Kidney Int 44:199-207, 1993
25. MATTHEWS DE, FONG Y: Amino acid and protein metabolism, in Clinical Nutrition: Parenteral Nutrition, edited by ROMBEAU JL, CALDWELL MD, Philadelphia, W.B. Saunders, 1993, p 75
26. SCANES CG: Growth hormone action: Protein metabolism, in Growth Hormone, edited by HARVEY S, SCANES CG, DAUGHADAY WH, Baco Raton, CRC Press, 1995, p 389
27. CLEMMONS DR, SMITH-BANKS A, UNDERWOOD LE: Reversal of diet-induced catabolism by infusion of recombinant insulin-like growth factor(IGF-1) in humans. J Clin Endocrinol Metab 75:234-238, 1992
28. KRIEG JRJ, SANTOS F, CHAN JCM: Growth hormone, insulin-like growth factor and the kidney. Kidney Int 48:321-336, 1995
29. FONG D, PENG SC, KOPPLE JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47:876-883, 1995
30. MAURAS N, HORBER F, HAYMOND M: Low dose recombinant human insulin-like growth factor-1 fails to affect protein anabolism but inhibits islet cell secretion in humans. J Clin Endocrinol Metab 75:1192-1197, 1992